4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-019646
Chief Financial Officer sold 10,000 shares at an average $147.30 ($1,472,954)
- Chief Financial Officer acquired 19,583 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
McAnear Justin J. · Chief Financial Officer
Table I: Non-derivative
14 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-08 | Exercise or conversion : show line 1 in the form | +10,000 | $5.04 | $50,400 | 30,774 | D |
| 2021-03-08 | Sale : show line 2 in the form | −1,022 | $141.25 | $144,357 | 29,752 | D |
| 2021-03-08 | Sale : show line 3 in the form | −400 | $142.49 | $56,994 | 29,352 | D |
| 2021-03-08 | Sale : show line 4 in the form | −1,100 | $145.03 | $159,528 | 28,252 | D |
| 2021-03-08 | Sale : show line 5 in the form | −1,902 | $145.90 | $277,501 | 26,350 | D |
| 2021-03-08 | Sale : show line 6 in the form | −1,476 | $146.88 | $216,793 | 24,874 | D |
| 2021-03-08 | Sale : show line 7 in the form | −200 | $148.08 | $29,616 | 24,674 | D |
| 2021-03-08 | Sale : show line 8 in the form | −1,100 | $149.43 | $164,371 | 23,574 | D |
| Open-market sales · 10,000 sh · avg $147.30 · $1,472,954 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-03-08 | Exercise or conversion : show line 15 in the form Stock Option (right to buy) | −10,000 | $5.04 | 2028-11-02 | 10,000 | 450,159 | D |
| 2021-03-10 | Exercise or conversion : show line 16 in the form Stock Option (right to buy) | −9,583 | $11.48 | 2029-05-10 | 9,583 | 10,417 | D |
Loading xslF345X03/doc4.xml…